Search

everythinglearnresearchcommunity

for

Search:↓

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

The combination treatment showed a higher response rate but no significant survival benefits.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Combining genetic and physical data improves diagnosis and treatment for early-onset monogenic diabetes.

New gene variants were found for rare skin and hair disorders, improving understanding and treatment.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Fibromodulin might help reduce scarring if increased in adult wounds like in fetal skin that heals without scars.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.